Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBAK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MIR6836 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUDT14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CFAP36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LYRM7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BTG3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMBIM4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBXO9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SCAI - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZNF839 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SMU1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PIK3CA - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRR14L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STAT5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R5E - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CUL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HSDL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RBM25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on